{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:14:09Z","timestamp":1777493649077,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["93-04-159-27489"],"award-info":[{"award-number":["93-04-159-27489"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jcjd.2016.09.015","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T15:47:03Z","timestamp":1482508023000},"page":"211-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Does Resveratrol Improve Insulin Signalling in HepG2 Cells?"],"prefix":"10.1016","volume":"41","author":[{"given":"Marjan","family":"Norouzzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemehsadat","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Akbar","family":"Saboor-Yaraghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farnoosh","family":"Shemirani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yas","family":"Kalikias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loghman","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monireh Sadat","family":"Seyyedsalehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2016.09.015_bib0010","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/414821a","article-title":"New drug targets for type 2 diabetes and the metabolic syndrome","volume":"414","author":"Moller","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001","volume":"289","author":"Mokdad","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1475-2840-11-15","article-title":"Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes","volume":"11","author":"Skov","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0025","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0030","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1126\/science.1092952","article-title":"Insulin signaling in health and disease","volume":"302","author":"White","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2006.08.033","article-title":"SIN1\/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity","volume":"127","author":"Jacinto","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"mTOR: From growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Zoncu","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0045","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1038\/emboj.2010.271","article-title":"mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide","volume":"29","author":"Oh","year":"2010","journal-title":"EMBO J"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0050","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.22887","article-title":"Role of adenosine monophosphate-activated protein kinase\u2013p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha\u2013dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones","volume":"49","author":"Hwahng","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.gde.2012.12.005","article-title":"mTOR in aging, metabolism, and cancer","volume":"23","author":"Cornu","year":"2013","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0060","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cmet.2012.03.015","article-title":"Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c","volume":"15","author":"Hagiwara","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0065","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1541-4337.2008.00048.x","article-title":"Bioactivity of flavonoids on insulin-secreting cells","volume":"7","author":"Pinent","year":"2008","journal-title":"Comprehen Rev Food Sci Food Saf"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0070","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1021\/jf0112973","article-title":"Plant foods and herbal sources of resveratrol","volume":"50","author":"Burns","year":"2002","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0075","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1096\/fj.03-0168rev","article-title":"Resveratrol: From grapevines to mammalian biology","volume":"17","author":"Pervaiz","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1089\/rej.2006.9.402","article-title":"Werner syndrome as an example of inflamm-aging: Possible therapeutic opportunities for a progeroid syndrome?","volume":"9","author":"Davis","year":"2006","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3164\/jcbn.10-119","article-title":"Hypoglycemic effect of resveratrol in type 2 diabetic model db\/db mice and its actions in cultured L6 myotubes and RIN-5F pancreatic \u03b2-cells","volume":"48","author":"Minakawa","year":"2011","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0090","doi-asserted-by":"crossref","first-page":"ra46","DOI":"10.1126\/scisignal.2001465","article-title":"The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy","volume":"4","author":"Sundaresan","year":"2011","journal-title":"Sci Signal"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0095","first-page":"25","article-title":"Resveratrol downregulates PI3K\/Akt\/mTOR signaling pathways in human U251 glioma cells","volume":"8","author":"Jiang","year":"2009","journal-title":"J Exp Ther Oncol"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0100","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1042\/BJ20070236","article-title":"Resveratrol is a class IA phosphoinositide 3-kinase inhibitor","volume":"406","author":"Frojdo","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0105","doi-asserted-by":"crossref","first-page":"7772","DOI":"10.1073\/pnas.95.13.7772","article-title":"Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway","volume":"95","author":"Scott","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0110","doi-asserted-by":"crossref","first-page":"33085","DOI":"10.1074\/jbc.274.46.33085","article-title":"Opposite translational control of GLUT1 and GLUT4 glucose transporter mRNAs in response to insulin: Role of mammalian target of rapamycin, protein kinase b, and phosphatidylinositol 3-kinase in GLUT1 mRNA translation","volume":"274","author":"Taha","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0115","doi-asserted-by":"crossref","first-page":"10446","DOI":"10.3390\/ijms150610446","article-title":"Triterpenoid saponins from stauntonia chinensis ameliorate insulin resistance via the AMP-activated protein kinase and IR\/IRS-1\/PI3K\/Akt pathways in insulin-resistant HepG2 Cells","volume":"15","author":"Hu","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0120","first-page":"28","article-title":"Hyperglycemia induction in HepG2 cell line","volume":"2","author":"Mohamadpour","year":"2016","journal-title":"Int J Health Stud"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0125","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2522\/ptj.20080008","article-title":"Diabetes-related microvascular and macrovascular diseases in the physical therapy setting","volume":"88","author":"Cade","year":"2008","journal-title":"Phys Ther"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0130","series-title":"The role of liver X receptor in hepatic de novo lipogenesis and cross-talk with insulin and glucose signaling","author":"Gr\u00f8nning-Wang","year":"2013"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0135","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1074\/jbc.M608216200","article-title":"Resveratrol binds to the sulfonylurea receptor SUR. and induces apoptosis in a SUR subtype-specific manner","volume":"282","author":"Hambrock","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0140","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/gerona\/glq184","article-title":"Resveratrol improves insulin resistance hyperglycemia and hepatosteatosis but not hypertriglyceridemia, inflammation, and life span in a mouse model for Werner syndrome","volume":"66","author":"Labbe","year":"2011","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0145","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-8-40","article-title":"Resveratrol inhibits nonalcoholic fatty liver disease in rats","volume":"8","author":"Bujanda","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0150","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.phrs.2012.05.003","article-title":"Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats","volume":"66","author":"Bagul","year":"2012","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0155","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2337\/db12-0975","article-title":"High-dose resveratrol supplementation in obese men: An investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition","volume":"62","author":"Poulsen","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4142\/jvs.2014.15.2.179","article-title":"Effects of resveratrol on the insulin signaling pathway of obese mice","volume":"15","author":"Hong","year":"2014","journal-title":"J Vet Sci"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0165","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cmet.2007.08.014","article-title":"SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B","volume":"6","author":"Sun","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.gene.2015.06.019","article-title":"Resveratrol improves hepatic insulin signaling and reduces the inflammatory response in streptozotocin-induced diabetes","volume":"570","author":"Sadi","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0175","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.metabol.2011.08.003","article-title":"Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: In vitro and in vivo experiments in rodents","volume":"61","author":"Kang","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0180","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0185","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2004-0921","article-title":"Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: Possible involvement in obesity-linked insulin resistance","volume":"146","author":"Khamzina","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0190","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature02866","article-title":"Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity","volume":"431","author":"Um","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0195","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1126\/science.1215135","article-title":"Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity","volume":"335","author":"Lamming","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0200","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.4161\/cc.8.12.8810","article-title":"At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence","volume":"8","author":"Demidenko","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/mnfr.201100400","article-title":"Resveratrol in human cancer chemoprevention: Choosing the \u2018right\u2019dose","volume":"56","author":"Scott","year":"2012","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0210","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jchromb.2006.10.017","article-title":"Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography","volume":"848","author":"Boocock","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0215","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1158\/1055-9965.EPI-07-0022","article-title":"Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent","volume":"16","author":"Boocock","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0220","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1172\/JCI46243","article-title":"Hepatic Sirt1 deficiency in mice impairs mTorc2\/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance","volume":"121","author":"Wang","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0225","doi-asserted-by":"crossref","first-page":"17179","DOI":"10.1074\/jbc.274.24.17179","article-title":"Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B","volume":"274","author":"Rena","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0230","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bbrc.2010.11.028","article-title":"Role of resveratrol in FOXO1-mediated gluconeogenic gene expression in the liver","volume":"403","author":"Park","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0235","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1101\/gad.1467506","article-title":"Mammalian sirtuins: Emerging roles in physiology, aging, and calorie restriction","volume":"20","author":"Haigis","year":"2006","journal-title":"Genes Dev"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0240","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.bbrc.2009.01.163","article-title":"Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1\u2013FOXO1 signaling pathway","volume":"380","author":"Wang","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0245","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng890","article-title":"Regulation of insulin action and pancreatic \u03b2-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1","volume":"32","author":"Nakae","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0250","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature01667","article-title":"Insulin-regulated hepatic gluconeogenesis through FOXO1\u2013PGC-1\u03b1 interaction","volume":"423","author":"Puigserver","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0255","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.4238\/2015.June.18.3","article-title":"FOXO1 is a tumor suppressor in cervical cancer","volume":"14","author":"Zhang","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.jcjd.2016.09.015_bib0260","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ygyno.2012.03.012","article-title":"Mitogenic and anti-apoptotic effects of insulin in endometrial cancer are phosphatidylinositol 3-kinase\/Akt dependent","volume":"125","author":"Wang","year":"2012","journal-title":"Gynecol Oncol"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267115300800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267115300800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:30:13Z","timestamp":1761492613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267115300800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1499267115300800"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2016.09.015","relation":{},"ISSN":["1499-2671"],"issn-type":[{"value":"1499-2671","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Resveratrol Improve Insulin Signalling in HepG2 Cells?","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2016.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Canadian Diabetes Association.","name":"copyright","label":"Copyright"}]}}